In a report released yesterday, Daniel Clark from Leerink Partners maintained a Buy rating on Zoetis (ZTS – Research Report), with a price target of $205.00. Discover outperforming stocks and ...
Parsippany, New Jersey-based Zoetis Inc. (ZTS) discovers, develops, and commercializes animal health medicines, vaccines, and diagnostic products and services. With a market cap of $75.4 billion ...
Leerink Partners analyst Daniel Clark reiterated a Buy rating on Zoetis (ZTS – Research Report) on January 13 and set a price target of $215.00. Discover outperforming stocks and invest smarter ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
After hours: January 17 at 7:55:19 PM EST Loading Chart for ZTS ...
After hours: 15 January at 18:29:12 GMT-5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback